Members of the European Parliament have formed a Pharmaceutical Intergroup, which held its first meeting in the third week of April in Strasbourg, it was reported at the third Annual Conference of European Medicines Agencies last week (see page 13). Intergroups consist of members of different parliamentary committees, meeting to discuss matters of mutual interest.
The meeting was opened by Sir James Black, and its topic was the protection and promotion of pharmaceutical innovation. Further meetings will be held shortly, one of which will focus on orphan drugs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze